Streetbeat News

Analyst Ratings

RH

Morgan Stanley analyst Simeon Gutman maintains an Equal-Weight rating on RH and raises the price target from $300 to $310.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:41 am

FULC

HC Wainwright & Co. has downgraded Fulcrum Therapeutics from Buy to Neutral and reduced the price target from $17 to $4, indicating a less optimistic outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:39 am

EQT

Morgan Stanley analyst Devin McDermott has reiterated an Overweight rating on EQT Corporation, maintaining a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:39 am

HAL

RBC Capital has downgraded Halliburton from Outperform to Sector Perform and reduced its price target from $44 to $37.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:37 am

GEV

Morgan Stanley analyst Andrew Percoco has maintained an Overweight rating on GE Vernova and raised the price target from $220 to $256.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:36 am

ORCL

Keybanc analyst Jason Ader maintains an Overweight rating on Oracle and raises the price target from $175 to $190.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:30 am

ADBE

Adobe shares declined after Q3 earnings, with Bernstein maintaining an Outperform rating but lowering the price target from $660 to $644.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:28 am

MPW

Truist Securities has maintained a Hold rating on Medical Properties Trust (NYSE:MPW) while raising the price target from $5 to $6.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:25 am

ATKR

Keybanc analyst Jeffrey Hammond maintains an Overweight rating on Atkore (NYSE:ATKR) but lowers the price target from $125 to $105.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:23 am

MRNA

Oppenheimer analyst Hartaj Singh has downgraded Moderna (NASDAQ:MRNA) from Outperform to Perform, indicating a neutral stance on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 11:23 am